Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agathe Vrillon

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Alzheimer'S Research & Therapy|December 23, 2020
Full-length and C-terminal neurogranin in Alzheimer's disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassaysAnnika Öhrfelt, Julien Dumurgier, Henrik Zetterberg, et al.
European Geriatric Medicine|March 28, 2023
Lumbar puncture training with healthcare simulation improves self-confidence and practical skills of French medical residents in geriatricsMatthieu Lilamand, Agathe Vrillon, Laurent Gonzales-Marabal, et al.
Journal of Neuroendocrinology|January 22, 2025
Plasma adiponectin and biomarker-confirmed Alzheimer's disease in a tertiary memory clinicLouise Sindzingre, Elodie Bouaziz-Amar, François Mouton-Liger, et al.
Maturitas|February 28, 2026
Assessment of medication-related risks for mortality prediction in Alzheimer's diseaseThéodore Decaix, Julien Dumurgier, Elodie Bouaziz-Amar, et al.
Journal of Neurochemistry|September 2, 2021
Amyloid pathology and synaptic loss in pathological agingEleni Gkanatsiou, Johanna Nilsson, Christina E Toomey, et al.
Alzheimer'S Research & Therapy|May 14, 2026
Clinical correlates of sleep profiles in dementia with Lewy bodies: a latent class approachLéa Renard, Clément Aveneau, Karl Götze, et al.
Journal of the American Geriatrics Society|October 12, 2020
COVID-19 in Older Adults: A Series of 76 Patients Aged 85 Years and Older with COVID-19Agathe Vrillon, Claire Hourregue, Julien Azuar, et al.
Clinical Chemistry and Laboratory Medicine|August 30, 2025
Cerebrospinal fluid leptin in Alzheimer's disease: relationship to plasma levels and to cerebrospinal amyloidElodie Bouaziz-Amar, Jeanne Neez, Fidaa Ibrahim, et al.
Alzheimer'S Research & Therapy|May 23, 2022
Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort studyAgathe Vrillon, François Mouton-Liger, Matthieu Martinet, et al.
International Journal of Molecular Sciences|November 11, 2022
Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical PracticeMatthieu Lilamand, Josué Clery, Agathe Vrillon, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Alzheimer'S Research & Therapy|December 23, 2020
Full-length and C-terminal neurogranin in Alzheimer's disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassaysAnnika Öhrfelt, Julien Dumurgier, Henrik Zetterberg, et al.
European Geriatric Medicine|March 28, 2023
Lumbar puncture training with healthcare simulation improves self-confidence and practical skills of French medical residents in geriatricsMatthieu Lilamand, Agathe Vrillon, Laurent Gonzales-Marabal, et al.
Journal of Neuroendocrinology|January 22, 2025
Plasma adiponectin and biomarker-confirmed Alzheimer's disease in a tertiary memory clinicLouise Sindzingre, Elodie Bouaziz-Amar, François Mouton-Liger, et al.
Maturitas|February 28, 2026
Assessment of medication-related risks for mortality prediction in Alzheimer's diseaseThéodore Decaix, Julien Dumurgier, Elodie Bouaziz-Amar, et al.
Journal of Neurochemistry|September 2, 2021
Amyloid pathology and synaptic loss in pathological agingEleni Gkanatsiou, Johanna Nilsson, Christina E Toomey, et al.
Alzheimer'S Research & Therapy|May 14, 2026
Clinical correlates of sleep profiles in dementia with Lewy bodies: a latent class approachLéa Renard, Clément Aveneau, Karl Götze, et al.
Journal of the American Geriatrics Society|October 12, 2020
COVID-19 in Older Adults: A Series of 76 Patients Aged 85 Years and Older with COVID-19Agathe Vrillon, Claire Hourregue, Julien Azuar, et al.
Clinical Chemistry and Laboratory Medicine|August 30, 2025
Cerebrospinal fluid leptin in Alzheimer's disease: relationship to plasma levels and to cerebrospinal amyloidElodie Bouaziz-Amar, Jeanne Neez, Fidaa Ibrahim, et al.
Alzheimer'S Research & Therapy|May 23, 2022
Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort studyAgathe Vrillon, François Mouton-Liger, Matthieu Martinet, et al.
International Journal of Molecular Sciences|November 11, 2022
Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical PracticeMatthieu Lilamand, Josué Clery, Agathe Vrillon, et al.
Pageof 6